The CHMP has issued a positive opinion recommending approval of an alternative dosing schedule for...
Galderma has announced new NEMLUVIO data to be presented at Fall Clinical 2026, including a...
AbbVie has announced that the SMC has accepted AQUIPTA (atogepant) for acute migraine treatment in...
Bespak has signed an MOU with SNBL to provide immediate and exclusive global access to...
RougeTx has launched with a $58 million series A financing to advance RTX‑001, a potential...